Accueil Ernstrade Bourse Actualite Stock


Copenhagen Stock Exchange

Bavarian Nordic A/S is a Denmark-based company active within the biopharmaceutical sector. The Company is primarily engaged in the development, production and marketing of vaccines against infectious and life-threatening diseases. Its business strategy focuses on three areas: Biodefense, Cancer and Infectious Diseases. Its product pipeline includes seven development programs, namely Smallpox (IMVAMUNE) and Anthrax in the Biodefense area; PROSTVAC, Prostate (MVA-BN PRO) and Breast (MVA-BN HER2) in the Cancer area, and HIV multiantigen and Measles/RSV in the Infectious Diseases area. The majority of programs are based on the Company’s patented technology MVA-BN. The Company has ongoing clinical programs in human immunodeficiency virus (HIV) and smallpox, as well as pre-clinical and research programs in a number of infectious diseases.



Copyright  2010 Ernstrade